The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
January 28th 2025
The new indication for semaglutide adds to the long list of conditions that the GLP-1 receptor agonist has been approved for, and provides a new option for high-risk patients with these chronic conditions.
Task Force Indecisive on Glaucoma Screening Recommendation
July 31st 2013Based on a review of studies on the risks and benefits of early screening and treatment for glaucoma, the United States Preventive Services Task Force concluded that it could not recommend for or against screening for asymptomatic adults.
Read More